天宇股份：公司原料药获得CEP证书

Group 1 - The company Tianyu Co., Ltd. (300702) announced on the evening of August 20 that it has received the Certificate of Suitability for European Pharmacopoeia (CEP) for the raw material drug Dabigatran Etexilate Mesylate issued by the European Directorate for the Quality of Medicines (EDQM) [1]